Covered recipient · General Payments record
GAYATHRI K DEVINENI
Allopathic & Osteopathic Physicians Pediatrics Pediatric Endocrinology
General Payments · PY2018–2024
$1,713.27
- Reported across 75 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $218.81 | 11 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $82.32 | 4 |
| Azurity Pharmaceuticals, Inc. | $38.58 | 2 |
| SANOFI-AVENTIS U.S. LLC | $29.55 | 1 |
| BETA BIONICS, INC. | $20.34 | 1 |
| Ascendis Pharma Inc | $18.52 | 1 |
| TOLMAR, INC. | $14.82 | 1 |
| BOSTON SCIENTIFIC CORPORATION | $14.68 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (11)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $20.00 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103602406 | CMS |
| ABBVIE INC. | $16.01 | 04/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103602408 | CMS |
| ABBVIE INC. | $19.40 | 06/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103602410 | CMS |
| ABBVIE INC. | $26.91 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103602412 | CMS |
| Ascendis Pharma Inc | $18.52 | 12/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133851919 | CMS |
| Azurity Pharmaceuticals, Inc. | $15.98 | 02/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134004791 | CMS |
| Azurity Pharmaceuticals, Inc. | $22.60 | 10/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134004793 | CMS |
| BETA BIONICS, INC. | $20.34 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087886783 | CMS |
| Boston Scientific Corporation | $14.68 | 10/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1092389136 | CMS |
| SANOFI-AVENTIS U.S. LLC | $29.55 | 11/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139871033 | CMS |
| Tolmar, Inc. | $14.82 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1138712276 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.